Northrop Grumman: Record Backlog, Tough Delivery | EP026

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Northrop Grumman: Record Backlog, Tough Delivery | EP026

Listen for free

View show details

Northrop Grumman: Record Backlog, Tough Delivery | EP026AI Investment Edge: Stocks, Markets & Money · Research checked 20 October 2026.Northrop’s record order book answers one question: customers want its systems. The harder investment question is how much becomes profitable delivery and cash after contract costs, factory investment and working capital.Explore the dated Northrop Grumman research at iPulse AI.Dated model view: The released September research assigned Buy at both its one-year and five-year horizons, with fixed endpoints 18 September 2027 and 18 September 2031. These are the ORIGINAL, non-adjusted rating labels on the 18 September 2026 reference of US$527.39, not a new score after today’s results or at the recording price. Current-reference scenario returns below are a separate calculation. The positive view depends on turning strategic demand into profitable production and cash.Finalization price refresh: a separate, later snapshotUS$538.13 was the latest available Alpaca IEX trade checked at finalization: 20 October 2026, 09:33:11.756 New York, Eastern Daylight Time. This is an intraday IEX print, not a certified consolidated close. With the same fixed 18 September 2027/2031 targets, the recalculated base price returns are +8.1079% / +53.8014%. Adding the same illustrative US$9.88/US$49.40 cash gives +9.9439% / +62.9814% gross, before tax and fees, without reinvestment.The continuous recording was completed before the market opened and explicitly uses the dated 19 October US$510.53 reference. Its rounded +14%/+62% price and +16%/+72% cash-inclusive figures remain correct for that recorded basis. The video card labels both snapshots separately. The later quote does not alter the archived model targets or constitute a fresh model rating.What Northrop sells, and who paysNorthrop Grumman develops, builds and supports stealth aircraft, strategic missiles, sensors, communications, space and missile-defense systems. The U.S. government accounted for 84% of 2025 sales, including prime and subcontract arrangements. Long contracts provide work visibility, while contract terms and delivery determine profit. Revenue recognition, customer cash receipts and reported earnings are different things.B-21 Raider and Sentinel make nuclear modernization central to the story. Mission electronics, communications and space diversify the business. Northrop does not own every missile or interceptor platform for which it supplies components.Four financial tests, checked against today’s Q3 resultsThe latest reported quarter ended 30 September 2026, with results released 20 October. The dated September AI consensus emphasized demand versus cash conversion, production economics, funding capacity and heavy investment. The fresh filing checks those four findings rather than silently turning the old research into a new model run.* Earnings and financial trend: Q3 sales were US$11.122bn, up 7% reported from US$10.423bn. Diluted EPS rose to US$7.89 from US$7.67. Research tax credits helped earnings: the effective tax rate fell to 13.4% from 16.9%, while pretax earnings declined 2%. Demand is converting into revenue, but sales growth alone does not explain per-share profit.* Profitability and margins: Q3 GAAP operating margin was 11.4%, versus 11.9% a year earlier. The separate non-GAAP segment margin was 12.1%, versus 12.3%. Aeronautics improved to 10.5% from 9.7%; Mission’s comparison included a prior-year US$68m favorable contract adjustment. Factory learning and contract mix matter; growth did not produce uniform margin expansion.* Balance sheet and leverage: September 30 cash was US$3.744bn, against US$15.197bn debt at carrying value—US$14.433bn long-term plus US$0.764bn current. This excludes lease and pension obligations. There is funding capacity alongside debt service and working-capital needs; a sovereign customer does not make the balance sheet risk-free. Unbilled receivables were US$7.899bn.* Capex and investment intensity: Nine-month capital expenditure was US$775m. The B-21 capacity agreement anticipates about US$2.5bn of company investment across multiple years, rather than a single-year expense. Cash goes out before the hoped-for manufacturing benefits, and favorable returns depend on delivery. The September debate about sustained factory investment remains a useful test, not a guarantee of an immediate cash release.One cash bridge: Q3 operating cash flow US$1.745bn − US$0.306bn capex + US$0.371bn customer-equipment sale proceeds = US$1.810bn company-defined adjusted free cash flow. Before the equipment-sale addition, the narrow CFO-minus-capex subtraction is US$1.439bn. The sale is included under the company’s non-GAAP definition; the whole US$1.810bn is not recurring operating cash. For context, nine-month operating cash was US$1.369bn and reported adjusted free cash flow US$965m. Quarterly and year-to-date amounts should not be interchanged.Current 2026 outlook: Northrop’s October 20 ...

No reviews yet